Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DH82BG
|
|||
| Drug Name |
ARQ-154
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Plaque psoriasis [ICD-11: EA90.0; ICD-10: L40.0; ICD-9: 696] | Phase 2 | [1] | |
| Company |
Arcutis Biotherapeutics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Phosphodiesterase 4 (PDE4) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04128007) Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Arcutis Biotherapeutics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.